Finance

Lists
MD:NYSE
Pediatrix Medical Group Inc
26,64 $
+1,52%
(+0,40) 1D
26,64 $
0,00% (0,00)
After hours
Closed: 9 қаз., 16:00:08 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MD...
Open
26,35 $
High
26,86 $
Low
26,33 $
Mkt. cap
2,16 млрд
Avg. vol.
743,79 м.
Volume
518,04 м.
P/E ratio
12,80
52-wk high
27,94 $
52-wk low
15,70 $
EPS
2,08 $
Beta
0,61
Shares outstanding
81,25 млн
No. of employees
4 мың
Open
26,35 $
High
26,86 $
Low
26,33 $
Mkt. cap
2,16 млрд
Avg. vol.
743,79 м.
Volume
518,04 м.
P/E ratio
12,80
52-wk high
27,94 $
52-wk low
15,70 $
EPS
2,08 $
Beta
0,61
Shares outstanding
81,25 млн
No. of employees
4 мың
News stories
From web sources and news partners
About Pediatrix Medical Group Inc
CEOJames D. Swift
Employees4,28 мың
Founded2007
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 6 analysts giving stock ratings to MD in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MD in the last 3 months.
Highest
Current 26,64 $
28,00 $ (+5,11%)
Average
27,40 $ (+2,85%)
Lowest
25,00 $ (-6,16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jack Slevin
Jefferies
Hold
Downgraded
28,00 $
+5,1%
08/19/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
28,00 $
+5,1%
08/11/2026
A.J. Rice
UBS
Hold
Maintained
28,00 $
+5,1%
08/06/2026
David S Macdonald
Truist Financial
Hold
Maintained
28,00 $
+5,1%
08/05/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
25,00 $
-6,2%
08/05/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/04/2026
Unknown Analyst
Mizuho Securities
Hold
Maintained
-
-
02/20/2026
Last report
2026 ж. 04 там.
Fiscal period
Q2 2026
0,63 $ / 0,59 $
+6,60%beat
Revenue / Est. (USD)
487,78 млн / 478,00 млн
+2,05%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
492,88 млн
493,77 млн
476,20 млн
487,78 млн
Cost of goods sold
352,53 млн
367,79 млн
363,23 млн
355,31 млн
Cost of revenue
352,53 млн
367,79 млн
363,23 млн
355,31 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60,79 млн
65,68 млн
60,27 млн
61,29 млн
Operating expense
66,34 млн
71,31 млн
66,38 млн
67,07 млн
Total operating expenses
418,87 млн
439,10 млн
429,62 млн
422,39 млн
Operating income
74,00 млн
54,67 млн
46,58 млн
65,40 млн
Other non operating income
-
-
-
-
EBT including unusual items
87,78 млн
45,60 млн
38,84 млн
54,00 млн
EBT excluding unusual items
72,83 млн
51,47 млн
43,77 млн
62,48 млн
Income tax expense
16,07 млн
11,91 млн
9,27 млн
14,16 млн
Effective tax rate
18,31%
26,13%
23,87%
26,22%
Other operating expenses
-
-
-
-
Net income
71,71 млн
33,68 млн
29,57 млн
39,84 млн
Net profit margin
14,55%
6,82%
6,21%
8,17%
Earnings per share
0,67
0,50
0,44
0,63
Interest and investment income
5,88 млн
4,70 млн
4,76 млн
4,55 млн
Interest expense
-8,94 млн
-8,74 млн
-8,26 млн
-8,17 млн
Net interest expenses
-3,06 млн
-4,04 млн
-3,50 млн
-3,62 млн
Depreciation and amortization charges
5,55 млн
5,63 млн
6,12 млн
5,78 млн
EBITDA
79,56 млн
60,30 млн
52,70 млн
71,18 млн
Gain or loss from assets sale
-20,91 млн
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары